Previous studies have found that HCP5 was shown to regulate neuroblastoma cells activation and promoted neuroblastoma progression by acting as ceRNA to bind with miR-186-5p and regulate MAP3K2 expression39. This evidence concerns the gene HCP5 and neuroblastoma.